Panacea Biotec Ltd receives additional award from UNICEF for supply of bOPV

Panacea Biotec Limited ("the Company") has received an additional Award from UNICEF for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 5.20 million (~Rs.44 Crore) in Q3 CY2025.

The company had earlier received Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 513.25 as compared to the previous close of Rs. 524.75. The total number of shares traded during the day was 71878 in over 2150 trades.

The stock hit an intraday high of Rs. 542.10 and intraday low of 498.55. The net turnover during the day was Rs. 36357746.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 UNICEF AdditionalOrder bOPV